8 results
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Vasopressors Table ... Book of Critical ... #Pharmacology # ... Effect #Management ... #Comparison #Inotropes
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
disease b) CHF ... event, follow ACC algorithm ... indicated • EKG ... Obtain EKG if: ... Change in clinical
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
cardiomyopathy (e.g ... May have typical HF ... hemodynamics (e.g ... LVEF recovery (e.g ... teratogenic GDMT meds (e.g
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
ECG is vital while ... #treatment #table ... #foamed #heartfailure ... #chf #criticalcare ... #pharmacology
Stiff Person Syndrome (SPS) - Diagnosis and Management Summary

Epidemiology:
 • Prevalence: 1-2 cases per million -
Clinical Manifestations ... unit activity on EMG ... of diazepam • EMG ... EMG Studies: ... #treatment #neurology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
may precede the neurologic ... Risk factors 3. ... • EEG: With persistent ... Syndrome #diagnosis #management ... #neurology
Amyotrophic Lateral Sclerosis (ALS) Summary
ALS: combination of the clinical examination finding of amyotrophy with the pathologic
in improperly folded ... Dysphagia- increased risk ... EMG: LMN Signs in ... Lateral #Sclerosis #neurology ... #diagnosis #management
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
Hepatotoxicity, QTc ... tolerable • Limited clinical ... #valleyfever #management ... #antifungals #comparison ... #table #pharmacology